The causes of Parkinson's disease (PD) have not yet been fully elucidated, but in addition to aging and genetic factors, ...

Research that won the 10th Bioindustry AwardOn July 15, 2026, Sumitomo Pharma Co., Ltd. and RACTHERA Inc. announced that the ...

Agenus Inc. has surged >195% YTD, driven by optimism around its BOT/BAL combo therapy for MSS colon cancer. Read more on AGEN ...

Summit and AstraZeneca have entered into an agreement whereby AstraZeneca will make an equity investment of $2.0 billion in convertible preferred shares. At the conversion ratio, the investment ...

Pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA), focused on CMC (Chemistry, Manufacturing, and Controls), is scheduled for October 2026, representing the ...

Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that data from the Phase III HARMONi-GI1 trial, conducted in China and sponsored by Akeso, Inc., featuring the novel, potential first-in-class ...

As you enter your 40s, the type of nutrients your body needs shifts. Adding supplements like vitamin D and B vitamins can ...

Five-year overall survival rate was 69.2%, adding to growing long-term evidence supporting the curative potential of CARVYKTI in earlier-line ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will host a virtual Capital Markets Event ...

Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia. SYDNEY, Sept. 22, 2026 /CNW/ -- Kazia Therapeutics Limited (NASDAQ: K ...

Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 10:00 AM EDTCompany ParticipantsTao Fu - ...

A psychiatric hospital chain based in Indiana says a 2022 leadership change brought major improvements. But WFYI found allegations of a patient death, abuse and serious safety violations continued — ...